Evidence map›Paper›PMID 20164351›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2010

Distinct roles of NR2A and NR2B cytoplasmic tails in long-term potentiation.

Kelly A Foster, Nathan McLaughlin, Dieter Edbauer, Marnie Phillips, Andrew Bolton, Martha Constantine-Paton, Morgan Sheng

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 214 citations in OpenAlex.

  1. Article
  2. Altered Structural Plasticity Mediated by mGlu and NMDA Receptors and Impaired Cognition in a Genetic ASD Model (Shank3The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Metabotropic NMDAR Signaling Contributes to Sex Differences in Synaptic Plasticity and Episodic Memory.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  7. Mechanisms of NMDA Receptor Inhibition by Biguanide Compounds.Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Synaptic memory and CaMKII.Physiological reviews · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Apamin structure and pharmacology revisited.Frontiers in pharmacology · 2022
    Article
  18. Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kelly A FosterDepartment of Basic Science, The Commonwealth Medical College, Scranton, Pennsylvania 18510, USA. kfoster@tcmedc.org
Nathan McLaughlin
Dieter Edbauer
Marnie Phillips
Andrew Bolton
Martha Constantine-Paton
Morgan Sheng
McGovern Institute for Brain Research · USGeisinger Commonwealth School of Medicine · US

Funding

Molecular organization of CNS synapsesR01MH076936 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHENG, MORGAN H. · 2005 to 2009
$992k
The Roles of NR2A and NR2B in Long-Term PlasticityF32NS055495 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOSTER, KELLY A · 2006 to 2008
$109k
Howard Hughes Medical InstituteNIMH NIH HHS MH076936NIMH NIH HHS R01 MH076936NINDS NIH HHS F32 NS055495NINDS NIH HHS F32NS055495-01
6 · The paper itself

Abstract

NMDA receptors (NMDARs) are critical mediators of activity-dependent synaptic plasticity, but the differential roles of NR2A- versus NR2B-containing NMDARs have been controversial. Here, we investigate the roles of NR2A and NR2B in long-term potentiation (LTP) in organotypic hippocampal slice cultures using RNA interference (RNAi) and overexpression, to complement pharmacological approaches. In young slices, when NR2B is the predominant subunit expressed, LTP is blocked by the NR2B-selective antagonist Ro25-6981 [R-(R,S)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propranol]. As slices mature and NR2A expression rises, activation of NR2B receptors became no longer necessary for LTP induction. LTP was blocked, however, by RNAi knockdown of NR2B, and this was rescued by coexpression of an RNAi-resistant NR2B (NR2B*) cDNA. Interestingly, a chimeric NR2B subunit in which the C-terminal cytoplasmic tail was replaced by that of NR2A failed to rescue LTP, whereas the reverse chimera, NR2A channel with NR2B tail, was able to restore LTP. Thus, expression of NR2B with its intact cytoplasmic tail is required for LTP induction, at an age when channel activity of NR2B-NMDARs is not required for LTP. Overexpression of wild-type NR2A failed to rescue LTP in neurons transfected with the NR2B-RNAi construct, despite restoring NMDA-EPSC amplitude to a similar level as NR2B*. Surprisingly, an NR2A construct lacking its entire C-terminal cytoplasmic tail regained its ability to restore LTP. Together, these data suggest that the NR2B subunit plays a critical role for LTP, presumably by recruiting relevant molecules important for LTP via its cytoplasmic tail. In contrast, NR2A is not essential for LTP, and its cytoplasmic tail seems to carry inhibitory factors for LTP.

Indexed as

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidAnimalsAnimals, NewbornBiophysicsCytoplasmElectric StimulationExcitatory Amino Acid AgentsExcitatory Postsynaptic PotentialsGene Expression RegulationGreen Fluorescent ProteinsHippocampusIn Vitro TechniquesLong-Term PotentiationN-MethylaspartatePatch-Clamp TechniquesPyramidal Cellsalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acidenhanced green fluorescent proteinExcitatory Amino Acid AgentsGreen Fluorescent ProteinsN-MethylaspartateNR2A NMDA receptorNR2B NMDA receptorReceptors, N-Methyl-D-AspartateRNA, Small Interfering

Identifiers

PMID20164351
PMCPMC2840640
OpenAlexW2132844263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.